What is the appropriate ondansetron (Zofran) dose for a 5‑year‑old child weighing 43 lb (≈19.5 kg) with normal liver function and no contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 5-Year-Old Weighing 43 Pounds

For a 5-year-old child weighing 43 lb (19.5 kg), administer ondansetron 0.15 mg/kg per dose, which equals approximately 3 mg per dose, with a maximum single dose of 8 mg for oral administration. 1

Weight-Based Calculation

  • The standard pediatric dose of ondansetron is 0.15 mg/kg per dose across all major guidelines. 1
  • For a 43 lb (19.5 kg) child: 19.5 kg × 0.15 mg/kg = 2.9 mg per dose (round to 3 mg for practical administration). 1
  • The maximum single oral dose is 8 mg, which this child does not approach. 1

Route and Frequency Selection

For Acute Gastroenteritis/Vomiting

  • Oral route: 3 mg as a single dose, using oral disintegrating tablet (ODT) or oral solution. 1
  • Intramuscular route: 3 mg (0.15 mg/kg) if the child cannot tolerate oral medication due to severe vomiting. 1
  • Intravenous route: 3 mg (0.15 mg/kg) if IV access is already established for fluid resuscitation. 1
  • Ondansetron can be repeated every 8 hours if needed, though a single dose is often sufficient for acute gastroenteritis. 1

For Chemotherapy-Induced Nausea (if applicable)

  • Administer 0.15 mg/kg IV or IM (3 mg for this child) 30 minutes before chemotherapy, then repeat at 4 and 8 hours after the first dose. 1
  • Combining ondansetron with dexamethasone significantly improves efficacy for highly emetogenic chemotherapy. 1

For Postoperative Nausea (if applicable)

  • Administer 0.1–0.15 mg/kg IV (2–3 mg for this child) immediately before or after anesthesia induction. 2

Formulation and Administration

  • Oral disintegrating tablet (ODT): Available in 4 mg and 8 mg strengths; give one 4 mg tablet (slightly higher than calculated 3 mg, but within safe range). 1
  • Oral solution: Typically 4 mg/5 mL concentration; administer 3.75 mL to deliver 3 mg. 1
  • Injectable formulation: 2 mg/mL concentration; draw up 1.5 mL for a 3 mg dose. 1
  • Ondansetron can be given without regard to meals, though administration with food may reduce mild gastrointestinal side effects. 1

Critical Safety Considerations

  • QT prolongation risk: Ondansetron prolongs the QT interval in a dose-dependent manner; the 0.15 mg/kg dose with an 8 mg maximum provides an appropriate safety margin. 1
  • Avoid in congenital long QT syndrome: Do not administer ondansetron to children with known congenital long QT syndrome or significant electrolyte abnormalities (hypokalemia, hypomagnesemia). 1
  • Age restriction for FPIES: While this 5-year-old is well above the minimum age, note that ondansetron should only be used in children ≥6 months of age for Food Protein-Induced Enterocolitis Syndrome. 1
  • Monitor for headache: Headache is the most common adverse effect, occurring in approximately 10–15% of pediatric patients, and is typically mild and self-limited. 2, 3

Common Pitfalls to Avoid

  • Do not exceed 8 mg per single oral dose in children, even if weight-based calculation suggests a higher dose. 1
  • Do not use the 16 mg maximum cited for IV chemotherapy dosing in routine gastroenteritis; the 8 mg oral maximum is appropriate for this indication. 1
  • Do not administer ondansetron to infants under 6 months unless the clinical situation is critical, due to limited safety data. 1
  • Do not use household measuring spoons for oral solution; always use a calibrated oral syringe or dosing cup. 1

References

Guideline

Ondansetron Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ondansetron: a novel antiemetic agent.

Southern medical journal, 1993

Related Questions

What is the appropriate ondansetron (Zofran) dose for a child weighing 15.8 kg with normal hepatic and renal function?
What is the appropriate dose of ondansetron (antiemetic medication) for a pediatric patient weighing 19.5kg?
Can an elderly female take Zofran (ondansetron)?
Should a 31-year-old female with a history of Nexplanon (etonogestrel implant) complications, presenting with left upper arm pain radiating to the wrist and thumb, and right arm burning pain at the antecubital (A/C) site, be evaluated in person or can she receive a refill for Ondansetron HCl (ondansetron hydrochloride) over the phone?
Is 3.5ml of ondansetron a suitable dose for an 18kg, 3-year-old child?
What is the appropriate assessment and follow‑up plan for an adult patient with incidental mild thoracic scoliosis (upper levoconvex Cobb angle 7.5°, lower dextro‑convex Cobb angle 9°), normal vertebral height and alignment, no fracture or subluxation, and mild multilevel degenerative disc disease with facet arthropathy?
In a female patient with myalgic encephalomyelitis/chronic fatigue syndrome and hyperadrenergic postural orthostatic tachycardia syndrome who is taking guanfacine 3 mg daily (which lowers blood pressure but does not improve hyperadrenergic symptoms), should the switch to clonidine be done via a complete guanfacine taper or a cross‑taper?
What are the recommended first‑line mood stabilizer options for a 12‑year‑old child?
For a 70‑kg adult with type 1 diabetes and normal renal function using an insulin pump, must I announce meals to the pump?
What central nervous system effects does severe hypothyroidism cause and how should it be treated, including appropriate levothyroxine dosing for elderly or cardiac patients and management of myxedema coma?
In an adult with alcohol use disorder who is opioid‑free and has adequate liver function, what oral and injectable naltrexone dosing schedule and minimum treatment duration are recommended, and which baseline and periodic laboratory tests should be performed to monitor safety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.